| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 001 | 3 | FDA | 9/5/2024 | $0 |
| | 2024 | 2023 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007657 | Integration of Drug Release and Permeability with Systems Data Relevant to PBPK Model of Nose-to-Brain Axis and Verification Using Clinical Data | 000 | 2 | FDA | 9/5/2024 | $0 |
| | 2024 | 2023 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 000 | 3 | FDA | 8/19/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $513,274 ) |
| | 2023 | 2023 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 001 | 3 | FDA | 7/31/2023 | $248,810 |
| | 2023 | 2023 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007657 | Integration of Drug Release and Permeability with Systems Data Relevant to PBPK Model of Nose-to-Brain Axis and Verification Using Clinical Data | 000 | 2 | FDA | 8/2/2023 | $264,446 |
| | 2023 | 2022 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 000 | 2 | FDA | 1/10/2023 | $0 |
| | 2023 | 2019 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 10 | NIH | 3/22/2023 | $0 |
| | 2023 | 2019 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 10 | NIH | 2/24/2023 | $18 |
|
| Issue Date FY: 2022 ( Subtotal = -$2,323,040 ) |
| | 2022 | 2022 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | | | GBR | U01FD007657 | Integration of Drug Release and Permeability with Systems Data Relevant to PBPK Model of Nose-to-Brain Axis and Verification Using Clinical Data | 000 | 1 | FDA | 9/9/2022 | $297,306 |
| | 2022 | 2022 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 000 | 2 | FDA | 7/22/2022 | $299,568 |
| | 2022 | 2019 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 10 | NIH | 11/22/2021 | -$1,691,777 |
| | 2022 | 2018 | THE UNIVERSITY OF MANCHESTER | OXFORD ROAD | MANCHESTER | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 9 | NIH | 11/22/2021 | -$1,228,137 |
|
| Issue Date FY: 2021 ( Subtotal = $296,354 ) |
| | 2021 | 2021 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 001 | 1 | FDA | 9/29/2021 | $0 |
| | 2021 | 2021 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | | | GBR | U01FD007348 | Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics | 000 | 1 | FDA | 9/21/2021 | $296,354 |
| | 2021 | 2019 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 10 | NIH | 2/17/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 10 | NIH | 4/1/2020 | $0 |
| | 2020 | 2019 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 10 | NIH | 3/12/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,691,777 ) |
| | 2019 | 2019 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 10 | NIH | 6/28/2019 | $1,691,777 |
| | 2019 | 2018 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 9 | NIH | 4/1/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,562,574 ) |
| | 2018 | 2018 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 9 | NIH | 6/26/2018 | $1,562,574 |
|
| Issue Date FY: 2017 ( Subtotal = $1,443,920 ) |
| | 2017 | 2017 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 002 | 8 | NIH | 6/22/2017 | $1,478,290 |
| | 2017 | 2015 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 6 | NIH | 12/22/2016 | $191,646 |
| | 2017 | 2012 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | R01DK077903 | Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy | 000 | 5 | NIH | 12/14/2016 | -$34,370 |
| | 2017 | 2012 | UNIVERSITY OF MANCHESTER | OXFORD RD | MANCHESTER | LANCASHIRE | M13 9PL | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 5 | NIH | 12/22/2016 | -$191,646 |
|
| Issue Date FY: 2016 ( Subtotal = $1,315,176 ) |
| | 2016 | 2016 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 7 | NIH | 6/17/2016 | $1,315,176 |
|
| Issue Date FY: 2015 ( Subtotal = $1,566,560 ) |
| | 2015 | 2015 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 002 | 6 | NIH | 9/24/2015 | $1,566,560 |
| | 2015 | 2012 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 5 | NIH | 5/11/2015 | $0 |
| | 2015 | 2012 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 001 | 5 | NIH | 9/21/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $0 ) |
| | 2014 | 2012 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 5 | NIH | 4/28/2014 | $0 |
| | 2014 | 2011 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | R01DK071066 | Emotional Stress and Wound Healing in Diabetes | 000 | 5 | NIH | 3/24/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2011 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | R01DK071066 | Emotional Stress and Wound Healing in Diabetes | 000 | 5 | NIH | 3/21/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $1,103,550 ) |
| | 2012 | 2012 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | R01DK077903 | Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy | 000 | 5 | NIH | 2/27/2012 | $266,538 |
| | 2012 | 2012 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 5 | NIH | 5/29/2012 | $837,012 |
|
| Issue Date FY: 2011 ( Subtotal = $1,450,786 ) (Continued on the next page) |
| | 2011 | 2011 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | R01DK077903 | Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy | 000 | 4 | NIH | 3/18/2011 | $277,927 |
| | 2011 | 2011 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | R01DK077903 | Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy | 001 | 4 | NIH | 5/27/2011 | $18,888 |
| | 2011 | 2011 | UNIVERSITY OF MANCHESTER | CHRISTIE BUILDING | MANCHESTER M13 9PL | | | | GBR | U01DE018664 | TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up | 000 | 4 | NIH | 5/26/2011 | $937,760 |
|
